Peter Switzer interviews CEO Wayne Paterson in The CEO Master Class!, page-6

Interesting comments on the deal discussion with a Pharma company involving up fronts and milestones etc. This could be a great way to go with funds in the bank to develop other products, financial backing and marketing to take on the big guys and retain some of the profits for years to come.

If not, it will surely shake up the incumbents to sharpen their pencil. As mentioned though we need our market cap up as they won’t bid that much beyond our current value to provide what would be fair.

IMO this will be come more likely after the market digests the first TAVR results. Things are going to get super interesting at the end of this year and Q1 next year. The global market knows what a leading TAVR device is worth. It can take a while for the ASX to catch on but they will soon enough.